April 2025
·
8 Reads
Objectives Chronic inflammation drives numerous pathologies, necessitating novel therapeutics from natural sources. This study aimed to characterize the anti-inflammatory potential of Ailanthus altissima Swingle-derived total flavonoids (ASF), a traditional East Asian remedy, and establish its pharmacological foundation for treating cytokine-mediated inflammatory diseases. Methods ASF's anti-inflammatory activity was evaluated in LPS-stimulated RAW 264.7 macrophages, measuring nitric oxide (NO), reactive oxygen species (ROS), and cytokines (TNF-α, IL-1β). LC-MS identified ASF constituents, while network pharmacology predicted interactions with inflammation targets (NF-κB, MAPK pathways). Extraction parameters were optimized via Box-Behnken design response surface methodology (RSM). Dose-response assays assessed ASF's suppression of inflammatory mediators. Results LC-MS identified 43 major ASF constituents. Network pharmacology revealed ASF's multi-target interactions with NF-κB and MAPK signaling. RSM optimization achieved a 10.4146% flavonoid yield. ASF dose-dependently inhibited NO by 68.2% (200 μg/mL, p < 0.01 versus LPS) and suppressed ROS/cytokines, demonstrating flavonoid-consistent structure-activity relationships. Conclusion ASF exhibits multi-target anti-inflammatory effects via NF-κB/MAPK modulation and mediator suppression, validating its traditional use. These findings support ASF's development as a phytopharmaceutical for cytokine-driven pathologies.